Abbott Laboratories Revenue 2012-2025 | ABT

Abbott Laboratories annual/quarterly revenue history and growth rate from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Abbott Laboratories revenue for the quarter ending September 30, 2025 was $11.369B, a 6.9% increase year-over-year.
  • Abbott Laboratories revenue for the twelve months ending September 30, 2025 was $43.843B, a 6.37% increase year-over-year.
  • Abbott Laboratories annual revenue for 2024 was $41.95B, a 4.59% increase from 2023.
  • Abbott Laboratories annual revenue for 2023 was $40.109B, a 8.12% decline from 2022.
  • Abbott Laboratories annual revenue for 2022 was $43.653B, a 1.34% increase from 2021.
Abbott Laboratories Annual Revenue
(Millions of US $)
2024 $41,950
2023 $40,109
2022 $43,653
2021 $43,075
2020 $34,608
2019 $31,904
2018 $30,578
2017 $27,390
2016 $20,853
2015 $20,405
2014 $20,247
2013 $19,657
2012 $19,050
2011 $21,407
Abbott Laboratories Quarterly Revenue
(Millions of US $)
2025-09-30 $11,369
2025-06-30 $11,142
2025-03-31 $10,358
2024-12-31 $10,974
2024-09-30 $10,635
2024-06-30 $10,377
2024-03-31 $9,964
2023-12-31 $10,241
2023-09-30 $10,143
2023-06-30 $9,978
2023-03-31 $9,747
2022-12-31 $10,091
2022-09-30 $10,410
2022-06-30 $11,257
2022-03-31 $11,895
2021-12-31 $11,468
2021-09-30 $10,928
2021-06-30 $10,223
2021-03-31 $10,456
2020-12-31 $10,701
2020-09-30 $8,853
2020-06-30 $7,328
2020-03-31 $7,726
2019-12-31 $8,314
2019-09-30 $8,076
2019-06-30 $7,979
2019-03-31 $7,535
2018-12-31 $7,765
2018-09-30 $7,656
2018-06-30 $7,767
2018-03-31 $7,390
2017-12-31 $7,589
2017-09-30 $6,829
2017-06-30 $6,637
2017-03-31 $6,335
2016-12-31 $5,333
2016-09-30 $5,302
2016-06-30 $5,333
2016-03-31 $4,885
2015-12-31 $5,188
2015-09-30 $5,150
2015-06-30 $5,170
2015-03-31 $4,897
2014-12-31 $5,356
2014-09-30 $5,079
2014-06-30 $5,057
2014-03-31 $4,755
2013-12-31 $4,008
2013-09-30 $4,825
2013-06-30 $5,446
2013-03-31 $5,378
2012-12-31 $3,188
2012-09-30 $5,265
2012-06-30 $5,313
2012-03-31 $5,284
2011-12-31 $10,377
2011-09-30 $9,817
2011-06-30 $9,616
2011-03-31 $9,041
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $218.959B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
EssilorLuxottica (ESLOY) France $150.458B 0.00
Boston Scientific (BSX) United States $144.746B 33.10
Stryker (SYK) United States $140.556B 27.91
Medtronic (MDT) Ireland $125.035B 17.32
Medline (MDLN) United States $53.232B 0.00
Lonza Group Ag (LZAGY) Switzerland $48.704B 0.00
Agilent Technologies (A) United States $42.105B 26.62
GE HealthCare Technologies (GEHC) United States $39.758B 19.01
ResMed (RMD) United States $36.846B 25.50
Koninklijke Philips (PHG) Netherlands $28.483B 18.60
Terumo (TRUMY) Japan $21.735B 24.47
Insulet (PODD) United States $20.333B 63.11
Zimmer Biomet Holdings (ZBH) United States $18.401B 11.48
Smith & Nephew SNATS (SNN) United Kingdom $14.263B 0.00
Baxter (BAX) United States $10.831B 8.74
Sunny Optical Technology (SNPTF) China $9.589B 0.00
Bio-Rad Laboratories (BIO) United States $8.735B 31.41
Demant (WILYY) Denmark $7.372B 0.00
Lantheus Holdings (LNTH) United States $4.480B 13.65
BillionToOne (BLLN) United States $3.933B 0.00
Envista Holdings (NVST) United States $3.885B 22.29
Haemonetics (HAE) United States $3.840B 17.09
ICU Medical (ICUI) United States $3.777B 23.98
Shandong Weigao Medical Polymer (SHWGF) China $3.099B 0.00
Prestige Consumer Healthcare (PBH) United States $3.086B 14.07
QuidelOrtho (QDEL) United States $2.286B 14.69
Neogen (NEOG) United States $2.093B 45.81
Perrigo (PRGO) Ireland $2.075B 5.20
AtriCure (ATRC) United States $2.061B 0.00
LeMaitre Vascular (LMAT) United States $1.928B 38.81
Curaleaf Holdings (CURLF) Canada $1.716B 0.00
Green Thumb Industries (GTBIF) United States $1.680B 73.64
Phibro Animal Health (PAHC) United States $1.599B 15.97
Lumexa Imaging Holdings (LMRI) United States $1.577B 0.00
Kestra Medical Technologies (KMTS) United States $1.425B 0.00
AdaptHealth (AHCO) United States $1.421B 20.57
BioLife Solutions (BLFS) United States $1.197B 355.14
Capricor Therapeutics (CAPR) United States $1.090B 0.00
Tilray Brands (TLRY) Canada $1.031B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.005B 0.00
InMode (INMD) Israel $0.913B 10.31
Omeros (OMER) United States $0.886B 0.00
CeriBell (CBLL) United States $0.865B 0.00
Valneva SE (VALN) France $0.850B 0.00
VAREX IMAGING (VREX) United States $0.563B 15.26
Verano Holdings (VRNO) United States $0.461B 0.00
Canopy Growth (CGC) Canada $0.453B 0.00
Brainsway (BWAY) Israel $0.453B 77.03
Cresco Labs (CRLBF) United States $0.443B 0.00
SNDL (SNDL) Canada $0.436B 0.00
Cerus (CERS) United States $0.396B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Evolus (EOLS) United States $0.366B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
TriSalus Life Sciences (TLSI) United States $0.290B 0.00
Viemed Healthcare (VMD) United States $0.275B 21.94
Sanuwave Health (SNWV) United States $0.266B 0.00
TerrAscend (TSNDF) Canada $0.242B 0.00
Aurora Cannabis (ACB) Canada $0.240B 141.00
High Tide (HITI) Canada $0.234B 0.00
Organigram Global (OGI) Canada $0.232B 0.00
Sanara MedTech (SMTI) United States $0.217B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Vireo Growth (VREOF) United States $0.208B 0.00
Utah Medical Products (UTMD) United States $0.192B 16.92
Accendra Health (ACH) United States $0.190B 1.91
OraSure Technologies (OSUR) United States $0.189B 0.00
Quipt Home Medical (QIPT) United States $0.154B 0.00
FitLife Brands (FTLF) United States $0.145B 0.00
Exagen (XGN) United States $0.144B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.137B 0.00
Apyx Medical (APYX) United States $0.133B 0.00
Jushi Holdings (JUSHF) United States $0.118B 0.00
Biote (BTMD) United States $0.118B 5.16
MacroGenics (MGNX) United States $0.116B 0.00
Fonar (FONR) United States $0.115B 16.71
ImmuCell (ICCC) United States $0.059B 24.98
Sharps Technology (STSS) United States $0.055B 0.00
Nephros (NEPH) United States $0.051B 37.00
Cytosorbents (CTSO) United States $0.042B 0.00
Jin Medical (ZJYL) China $0.039B 0.00
Veru (VERU) United States $0.038B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
United-Guardian (UG) United States $0.029B 14.53
Allurion Technologies (ALUR) United States $0.016B 0.00
Bonk (BNKK) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
INLIF (INLF) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Flora Growth (FLGC) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Agape ATP (ATPC) $0.004B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.000B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00